During the past decade, DJL Clinical Research, PLLC conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 22 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 17 clinical trials were completed. i.e. 113.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DJL Clinical Research, PLLC" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DJL Clinical Research, PLLC" #1 collaborator was "PPD" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "DJL Clinical Research, PLLC" are "Systemic Lupus Erythematosus" (8 trials), "Lupus Erythematosus, Systemic" (7 trials), "Rheumatoid Arthritis" (6 trials), "Arthritis, Rheumatoid" (3 trials) and "Cutaneous Lupus Erythematosus" (2 trials). Many other conditions were trialed in "DJL Clinical Research, PLLC" in a lesser frequency.

Most popular intervention types in "DJL Clinical Research, PLLC" are "Drug" (36 trials), "Other" (10 trials), "Biological" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Acthar Gel" (2 trials), "CC-220" (2 trials), "CHS-0214" (2 trials) and "Etanercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "DJL Clinical Research, PLLC" are 36 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "DJL Clinical Research, PLLC". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in DJL Clinical Research, PLLC, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in DJL Clinical Research, PLLC, 3 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".